{"id":206,"date":"2026-04-11T09:09:03","date_gmt":"2026-04-11T09:09:03","guid":{"rendered":"https:\/\/luciuspharmacy.com\/?post_type=product&#038;p=206"},"modified":"2026-09-30T09:01:21","modified_gmt":"2026-09-30T09:01:21","slug":"lucicapma-capmatinib","status":"publish","type":"product","link":"https:\/\/luciuspharmacy.com\/es\/product\/lucicapma-capmatinib\/","title":{"rendered":"LuciCapma"},"content":{"rendered":"<p style=\"line-height:20px\"><span style=\"font-size:16px;;color:#595959\"><strong>HIGHLIGHTS OF PRESCRIBING INFORMATION <\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>These highlights do not include all the information needed to use LuciCapma safely and effectively. See full prescribing information for LuciCapma.<\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>INDICATIONS AND USAGE<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">LuciCapma is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>DOSAGE AND ADMINISTRATION <\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">\u2022 Select patients for treatment with LuciCapma based on presence of a mutation that leads to MET exon 14 skipping. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">\u2022 Recommended Dosage: 400 mg orally twice daily with or without food. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>DOSAGE FORMS AND STRENGTHS <\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">Tablets: 200 mg\u00d760 tablets<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>CONTRAINDICATIONS <\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">None. (4) <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>WARNINGS AND PRECAUTIONS <\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">\u2022 Interstitial Lung Disease (ILD)\/Pneumonitis: Monitor for new or worsening pulmonary symptoms indicative of ILD\/pneumonitis. Permanently discontinue LuciCapma in patients with ILD\/pneumonitis. &nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">\u2022 Hepatotoxicity: Monitor liver function tests. Withhold, dose reduce, or permanently discontinue LuciCapma based on severity. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">\u2022&nbsp;Pancreatic Toxicity: Monitor amylase and lipase levels. Withhold, dose reduce, or permanently discontinue LuciCapma based on severity. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">\u2022 Hypersensitivity Reactions: Withhold or permanently discontinue LuciCapma based on severity. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">\u2022 Risk of Photosensitivity: May cause photosensitivity reactions. Advise patients to limit direct ultraviolet exposure. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">\u2022 Embryo-Fetal Toxicity: Can cause fetal harm. Advise patients of the potential risk to a fetus and to use effective contraception. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>ADVERSE REACTIONS <\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">The most common adverse reactions (\u2265 20%) are edema, nausea, musculoskeletal pain, fatigue, vomiting, dyspnea, cough, and decreased appetite.<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>DRUG INTERACTIONS <\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">Strong and Moderate CYP3A Inducers: Avoid concomitant use. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>USE IN SPECIFIC POPULATIONS <\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">Lactation: Advise not to breastfeed. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">&nbsp;<\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\"><strong>Storage <\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">Dispense in the original package with the desiccant cartridge. Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F), excursions permitted between 15\u00b0C and 30\u00b0C (59\u00b0F and 86\u00b0F) [see USP Controlled Room Temperature]. Protect from moisture. <\/span><\/p>\n<p style=\"line-height:20px\"><span style=\"font-size:16px;color:#595959\">Discard any unused LuciCapma remaining after 6 weeks of first opening the bottle.<\/span><\/p>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>LuciCapma contains capmatinib and is supplied as oral tablets. Please confirm the prescribed strength and review the full product information before ordering. A valid prescription and identity verification are required.<\/p>","protected":false},"featured_media":2166,"comment_status":"open","ping_status":"closed","template":"","meta":{"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_seo_schema_type":""},"product_brand":[],"product_cat":[19],"product_tag":[],"class_list":["post-206","product","type-product","status-publish","has-post-thumbnail","product_cat-lung-cancer","first","instock","shipping-taxable","purchasable","product-type-simple"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/product\/206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/comments?post=206"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/media\/2166"}],"wp:attachment":[{"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/media?parent=206"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/product_brand?post=206"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/product_cat?post=206"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/luciuspharmacy.com\/es\/wp-json\/wp\/v2\/product_tag?post=206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}